Market Tracker

09/16 6:05pm ET

Endocyte Inc (NASDAQ:ECYT)

7.92
Data as of Sep 16
 -0.23 / -2.82%
Today’s Change
5.91
Today|||52-Week Range
33.70
-25.84%
Year-to-Date

Today’s Trading

Previous close8.15
Today’s open8.02
Day’s range7.74 - 8.25
Volume1,051,232
Average volume (3 months)1,244,610
Market cap$338.6M
Dividend yield--
Data as of 3:59pm ET, 09/16/2014

Growth & Valuation

Earnings growth (last year)-4.17%
Earnings growth (this year)+94.66%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.04%
P/E ratio29.3
Price/Sales5.93
Price/Book3.34

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.08+0.76%
NWBONorthwest Biotherape...+0.29+5.21%
RPRXRepros Therapeutics ...+0.05+0.35%
SUPNSupernus Pharmaceuti...+0.12+1.48%
Data as of 3:59pm ET, 09/16/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$64.9M
Annual profit (last year)-$18.0M
Net profit margin-27.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts